Biocartis - Model ctKRAS - Fully Automated Mutation Test Covers System
From Idyllatm - Oncology Assays
The fully automated Idylla ctKRAS Mutation Test is minimally invasive, fast and easy to perform and can be used as complement to tissue testing to determine the RAS mutation status at diagnosis. IdyllaTM ctKRAS covers 21 KRAS mutations in exons 2,3 and 4 and showed an high concordance to NGS of 96% using plasma samples from 198 mCRC patients enrolled in the prospective multicenter RASANC study.1
-
Most popular related searches
Products Details
Specimen requirements
One of the biggest challenges in oncology biomarker testing is the ability to obtain samples of sufficient size and quality. With the IdyllaTM system only a minimal amount of sample is needed
- 1 ml plasma collected in Streck tubes (process within 3 days)
Customer reviews
No reviews were found for Biocartis - Model ctKRAS - Fully Automated Mutation Test Covers System. Be the first to review!